[Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
D000928:Antidepressive Agents / Q000494:pharmacology*; D002090:Butyrophenones / Q000494:pharmacology*; D002746:Chlorpromazine / Q000009:adverse effects / Q000494:pharmacology*; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D005260:Female; D005461:Fluorine / Q000494:pharmacology; D006801:Humans; D010880:Piperidines / Q000494:pharmacology*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology*; D014268:Trifluoperazine / Q000009:adverse effects / Q000494:pharmacology*; D014272:Trifluperidol / Q000009:adverse effects / Q000494:pharmacology
D000928:Antidepressive Agents; D002090:Butyrophenones; D010880:Piperidines; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D005461:Fluorine; D014272:Trifluperidol; D002746:Chlorpromazine
Neuroleptiques et effets extra-pyramidaux: correlation entre les proprietes antipsychotiques et extra-pyramidales.